P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM. (23rd June 2022) - Khan, E.; Nourse, J.; Tokalov, S.; Khokhar, S.; Arnold-Schild, D.; Schott, L.; Eder, L.; Danckwardt, S.